Vedolizumab may help eliminate HIV infection by attenuating lymphoid aggregates Oct. 9, 2018 No Comments
BIT225-009 phase II study demonstrates significant immunological benefits in HIV-infected patients Oct. 1, 2018 No Comments
IAVI enrolling healthy volunteers for first-in-human study of eOD-GT8 60mer vaccine, adjuvanted Sep. 4, 2018 No Comments
FDA approves Merck & Co.'s Delstrigo and Pifeltro for the treatment of HIV-1 Aug. 31, 2018 No Comments
Dissemination of data from four phase I studies GSK-2838232, a second-generation drug for HIV Aug. 29, 2018 No Comments
RSS